Coronavirus: What we know now in the race

to find answers to the outbreak — before it

finds us
U.S. health officials share new details about deaths,
diagnosis, treatment and prevention


ASSOCIATED PRESS
Passengers wear masks to prevent an outbreak of a new coronavirus in a subway
station, in Hong Kong, Wednesday, Jan. 22, 2020. The first case of coronavirus in
Macao was confirmed on Wednesday, according to state broadcaster CCTV. The
infected person, a 52-year-old woman, was a traveller from Wuhan. (AP Photo/Kin
Cheung)
By LISA M. KRIEGER | lkrieger@bayareanewsgroup.com | Bay Area News Group
PUBLISHED: January 28, 2020 at 1:42 pm | UPDATED: January 29, 2020 at 8:05 am
Since a mysterious illness first appeared in the central Chinese city of Wuhan in
December, there have been few hard facts about a virus that has now spread to 18
nations, including the United States.

On Tuesday, U.S. health officials shared new insights about the virus at a Washington
D.C. press conference. There is a race to find answers to the outbreak — before it finds
us.

Q: How is coronavirus diagnosed?

A: There’s a sophisticated new test called Reverse Transcriptase PCR (RT-PCR), which
measures the amount of viral RNA, a chain of cells that carry genetic information, in a
patient’s sputum, serum or blood. That’s why all samples are being shipped to Atlanta
and tested at the Centers for Disease Control labs.
Once the test is perfected and standardized, it will be released to states. Meanwhile,
experts are now trying to build a test that is quicker, easier and cheaper — something like
an HIV test, for instance, that can detect simple antibodies.

Q: How deadly is it?

A: About 106 of 4,500 patients have died in China — a 2.3% mortality rate. About 17%
of total cases are severely ill, according to Chinese authorities.
But the true course of the illness could be more benign. Experts say that, like other
epidemics, it was first detected in very sick people — because they’re the first to seek
medical help. These patients tend to be older or have other illnesses. People with mild
sniffles don’t show up. So the true mortality rate may drop over time as doctors study a
broader set of cases.

Q: Does it spread easily?

A: According to a report, one person will infect, on average, 1.5 to 3 people. That’s far
less scary than measles, where 12 to 18 people are infected by one sick person. But it
assures continued spread of the virus. To get an outbreak under control, the transmission
rate must fall below 1.
Q: How long does it take to get sick, after I’m exposed?
A: For related viruses, the so-called “incubation period” ranges from 2 to 14 days. That
number could be higher or lower for this virus.
Q: Can I catch it from someone who isn’t sick?
A: That’s controversial. In other coronaviruses, the disease only spreads when a person
has symptoms. In this outbreak, China says it has identified infections that were acquired
from people who seemed healthy. But there are only a few cases. And they haven’t been
confirmed by international experts.
If true, it could influence how we respond to the outbreak. Yet healthy carriers rarely fuel
major epidemics. Sick people — who cough and sneeze, spreading germs — are a far
bigger problem.

“Asymptomatic people have never been the driver of outbreaks,” said National Institute
of Allergy and Infectious Diseases director Dr. Anthony Fauci.

Q: Do we know the genetic sequence?

A: Yes. Chinese scientists posted it publicly within a few days, so international teams can
start studying it without obtaining a sample of the live virus.
Q: Is there treatment?
A: No. Unlike bacterial infections, which are generally easily treated by antibiotics,
viruses are tough to combat. And because coronaviruses aren’t common, they haven’t
gotten the full attention of the pharmaceutical industry. But there’s good news. Scientists
report some success in treating related viruses, called severe acute respiratory syndrome
coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-
CoV). So this research is accelerating, and will be applied the new virus.
 These promising new agents include: AbbVie’s Aluvia, Inovio Pharma’s INO-4700,
Biocryst Pharma’s Galidesivir, Regeneron’s REGN3048-3051 and Novavax’s MERS
coronavirus vaccine candidate.

Q: Is there a vaccine?
A: Not yet. Human testing will start within three months, according to NIAID’s Fauci.
The first trials, called Phase 1, will test safety and evidence of an immune response. If
results look promising, research will move into Phase 2 trials, which seek effectiveness.
Related Articles
 Coronavirus: How the Bay Area is responding
 Coronavirus: I’m sick. Is it a cold, flu or the new virus?
 Coronavirus: Can my dog or cat get it — and pass it along to me?
 Cartoons: Coronavirus kills dozens, spreads globally from China
 Coronavirus: Blame the bats
Once a vaccine is proven, it will take time to be mass-produced and distributed to the
general public.
Sources: Department of Health and Human Services secretary Alex Azar; Centers for
Disease Control and Prevention director Robert Redfield; National Center for
Immunization and Respiratory Disease director director Nancy Messonnier; National
Institute of Allergy and Infectious Diseases director Anthony Fauci.